Renaissance Technologies’s Viridian Therapeutics VRDN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-320,300
Closed -$4.32M 3935
2025
Q1
$4.32M Sell
320,300
-50,900
-14% -$686K 0.01% 1525
2024
Q4
$7.12M Buy
371,200
+311,600
+523% +$5.97M 0.01% 1223
2024
Q3
$1.36M Sell
59,600
-188,000
-76% -$4.28M ﹤0.01% 2262
2024
Q2
$3.22M Sell
247,600
-14,100
-5% -$183K 0.01% 1573
2024
Q1
$4.58M Buy
261,700
+248,300
+1,853% +$4.35M 0.01% 1467
2023
Q4
$292K Sell
13,400
-51,800
-79% -$1.13M ﹤0.01% 3000
2023
Q3
$1M Sell
65,200
-10,800
-14% -$166K ﹤0.01% 2295
2023
Q2
$1.81M Buy
76,000
+40,200
+112% +$956K ﹤0.01% 2067
2023
Q1
$911K Buy
+35,800
New +$911K ﹤0.01% 2540
2022
Q4
Sell
-101,600
Closed -$2.08M 4448
2022
Q3
$2.08M Buy
+101,600
New +$2.08M ﹤0.01% 1976
2021
Q2
Sell
-13,240
Closed -$221K 3802
2021
Q1
$221K Sell
13,240
-40,162
-75% -$670K ﹤0.01% 3124
2020
Q4
$878K Buy
53,402
+48,361
+959% +$795K ﹤0.01% 2566
2020
Q3
$59K Sell
5,041
-32,007
-86% -$375K ﹤0.01% 3260
2020
Q2
$617K Sell
37,048
-3,227
-8% -$53.7K ﹤0.01% 2791
2020
Q1
$270K Buy
40,275
+9,339
+30% +$62.6K ﹤0.01% 3013
2019
Q4
$223K Buy
30,936
+17,355
+128% +$125K ﹤0.01% 3166
2019
Q3
$149K Buy
13,581
+1,614
+13% +$17.7K ﹤0.01% 3210
2019
Q2
$368K Buy
11,967
+2,307
+24% +$70.9K ﹤0.01% 3102
2019
Q1
$404K Sell
9,660
-793
-8% -$33.2K ﹤0.01% 3003
2018
Q4
$475K Buy
+10,453
New +$475K ﹤0.01% 2882
2018
Q2
Sell
-2,048
Closed -$215K 3554
2018
Q1
$215K Sell
2,048
-3,419
-63% -$359K ﹤0.01% 3166
2017
Q4
$855K Buy
+5,467
New +$855K ﹤0.01% 2725
2017
Q1
Sell
-706
Closed -$53K 3426
2016
Q4
$53K Buy
706
+538
+320% +$40.4K ﹤0.01% 3161
2016
Q3
$19K Buy
168
+100
+147% +$11.3K ﹤0.01% 3289
2016
Q2
$6K Buy
+68
New +$6K ﹤0.01% 3297